ATE141613T1 - Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür - Google Patents

Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür

Info

Publication number
ATE141613T1
ATE141613T1 AT91906948T AT91906948T ATE141613T1 AT E141613 T1 ATE141613 T1 AT E141613T1 AT 91906948 T AT91906948 T AT 91906948T AT 91906948 T AT91906948 T AT 91906948T AT E141613 T1 ATE141613 T1 AT E141613T1
Authority
AT
Austria
Prior art keywords
diketopiperazine
intermediate products
dkp
new intermediate
derivatives
Prior art date
Application number
AT91906948T
Other languages
English (en)
Inventor
John B Hill
Tse-Lok Ho
Mark R Johnson
Russell Klix
Gayle Webber
Robert A Erickson
Original Assignee
Nutrasweet Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrasweet Co filed Critical Nutrasweet Co
Application granted granted Critical
Publication of ATE141613T1 publication Critical patent/ATE141613T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06104Dipeptides with the first amino acid being acidic
    • C07K5/06113Asp- or Asn-amino acid
    • C07K5/06121Asp- or Asn-amino acid the second amino acid being aromatic or cycloaliphatic
    • C07K5/0613Aspartame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91906948T 1990-03-15 1991-03-12 Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür ATE141613T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49824390A 1990-03-15 1990-03-15
US60665690A 1990-10-31 1990-10-31
US65878491A 1991-02-26 1991-02-26
US66480691A 1991-03-08 1991-03-08

Publications (1)

Publication Number Publication Date
ATE141613T1 true ATE141613T1 (de) 1996-09-15

Family

ID=27504394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906948T ATE141613T1 (de) 1990-03-15 1991-03-12 Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür

Country Status (16)

Country Link
EP (1) EP0478729B1 (de)
CN (1) CN1057835A (de)
AT (1) ATE141613T1 (de)
AU (1) AU628257B2 (de)
CA (1) CA2060515A1 (de)
CS (1) CS70091A2 (de)
DE (1) DE69121502T2 (de)
DK (1) DK0478729T3 (de)
ES (1) ES2091324T3 (de)
GR (1) GR3020839T3 (de)
HU (1) HUT60712A (de)
IE (1) IE910896A1 (de)
NO (1) NO920193L (de)
NZ (1) NZ237469A (de)
PT (1) PT97049B (de)
WO (1) WO1991014378A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04234375A (ja) * 1990-12-27 1992-08-24 Ajinomoto Co Inc 新規2,5−ジオキソピペラジン化合物及びその製造法
JPH04234374A (ja) * 1990-12-27 1992-08-24 Ajinomoto Co Inc ジケトピペラジン誘導体の製造方法
JPH05117246A (ja) * 1991-10-23 1993-05-14 Ajinomoto Co Inc 新規2,5−ジオキソピペラジン化合物とその製造法及びα−L−アスパルチル−L−フエニルアラニンメチルエステル誘導体の製造法
US6465677B1 (en) 1998-11-19 2002-10-15 The Nutrasweet Company Method for the preparation of N-neohexyl-α-aspartyl-L-phenylalanine methyl ester from imidazolidin-4-one intermediates
DE10019879A1 (de) * 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
CN100553636C (zh) 2000-08-04 2009-10-28 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
GB2382346B (en) * 2000-08-04 2004-08-11 Dmi Biosciences Inc Method of synthesizing diketopiperazines
WO2004030522A2 (en) 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
EP2517718B1 (de) 2003-05-15 2016-03-02 Ampio Pharmaceuticals, Inc. Behandlung von T-Zell-vermittelten Krankheiten
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2771007B1 (de) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Behandlung von rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
EP3310375A4 (de) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Verwendung von niedermolekularen fraktionen von humanem serumalbumin bei der behandlung von erkrankungen
US11510427B2 (en) * 2016-12-21 2022-11-29 Suntory Holdings Limited Food and beverages containing cyclo(aspartyl-glycine), glucose, and maltose
JPWO2024075813A1 (de) * 2022-10-07 2024-04-11

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2038106A1 (de) * 1970-07-31 1972-02-10 Henkel & Cie Gmbh Aktivatoren fuer Perverbindungen
JPS58185545A (ja) * 1982-04-22 1983-10-29 Ajinomoto Co Inc α−L−アスパルチル−L−フエニルアラニンメチルエステルまたはその塩酸塩の製法
IT1197461B (it) * 1983-05-13 1988-11-30 Debi Derivati Biologici Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina
JPS60174799A (ja) * 1984-02-21 1985-09-09 Ajinomoto Co Inc α−L−アスパルチル−L−フエニルアラニンメチルエステルの製造法
AU586669B2 (en) * 1985-03-29 1989-07-20 Mitsui Toatsu Chemicals Inc. Preparation process of ```-L-aspartyl-L-phenylalanine methyl ester or hydrochloride thereof
JPH0647600B2 (ja) * 1985-06-04 1994-06-22 味の素株式会社 β−アスパルチルフエニルアラニン誘導体のα−アスパルチルフエニルアラニン誘導体への変換法
US4677220A (en) * 1985-10-31 1987-06-30 Monsanto Company Process for the preparation of α-L-aspartyl-L-phenylalanine methyl ester
DE3600731A1 (de) * 1986-01-13 1987-07-16 Green Cross Korea Verfahren zur herstellung von (alpha)-l-aspartyl-l-phenylalaninmethylester
US4992552A (en) * 1988-08-31 1991-02-12 Eastman Kodak Company Process for preparation of amino acids

Also Published As

Publication number Publication date
NO920193D0 (no) 1992-01-15
DE69121502T2 (de) 1997-01-16
EP0478729A4 (en) 1993-06-16
EP0478729A1 (de) 1992-04-08
IE910896A1 (en) 1991-09-25
EP0478729B1 (de) 1996-08-21
AU7564891A (en) 1991-10-21
ES2091324T3 (es) 1996-11-01
AU628257B2 (en) 1992-09-10
CN1057835A (zh) 1992-01-15
HUT60712A (en) 1992-10-28
WO1991014378A1 (en) 1991-10-03
DE69121502D1 (de) 1996-09-26
NZ237469A (en) 1993-08-26
NO920193L (no) 1992-01-15
CS70091A2 (en) 1991-10-15
DK0478729T3 (da) 1996-09-16
GR3020839T3 (en) 1996-11-30
PT97049A (pt) 1991-12-31
CA2060515A1 (en) 1991-09-16
PT97049B (pt) 1998-07-31

Similar Documents

Publication Publication Date Title
ATE141613T1 (de) Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür
DE69316405D1 (de) Verfahren zur fermentativen Herstellung von Aminosäuren
DE69132176D1 (de) Verfahren zur Herstellung von Elektroden
DE69832209D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutyraldehyd durch Oxidation von 3,3-Dimethylbutanol
DE68919246D1 (de) Verfahren zur Herstellung von Aminosäuren.
DE69611957D1 (de) Verfahren zur Herstellung von Goldpulver durch Aerosolzersetzungen
DE69328761D1 (de) Verfahren zur Herstellung von L-Tryptophan, L-Tyrosin oder L-Phenylalanin
DE68913394D1 (de) Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen.
DE69531308D1 (de) Verfahren zur Herstellung von gereinigten papillomavirus Proteinen
DE3583220D1 (de) Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
IL98647A0 (en) Anti-inflammatory factor,processes for the preparation thereof and pharmaceutical compositions containing the same
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE69220113D1 (de) Verfahren zur Herstellung von menschlichem Serum Albumin
DE69306016D1 (de) Verfahren zur Herstellung von Acrolein
DE69607524D1 (de) Verfahren zur Herstellung von einem Bicyclohexanderivat
DE69611120D1 (de) Verfahren zur Herstellung von "grüner-Tee-Eiern"
DE59007794D1 (de) Verfahren zur Herstellung von 2-Chlor-5-chlormethyl-pyridin und neue Zwischenprodukte.
DE69530176T2 (de) Verfahren zur Herstellung von Protein
DE69113323D1 (de) Verfahren zur Herstellung von alpha-Hydroxycarbonsäure amiden.
DE59309922D1 (de) Verfahren zur Herstellung von substituierten 2,3-Difluorpyridinen
DE59510265D1 (de) Verfahren zur Herstellung von 2,6-Dichlor-3-fluor-benzonitril und neue Zwischen-produkte
FR2625651B1 (fr) Procede d'elimination de l'amertume d'hydrolysats de proteines et produit obtenu
DE59107146D1 (de) Verfahren zur Herstellung von T-Gate-Elektroden
DE69500362D1 (de) Verfahren zur Herstellung 5,6-dihydroxyindol-Derivate ausgehend von Dopa
DE59300584D1 (de) Verfahren zur Herstellung von 5-Cyanvaleriansäureamid.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee